General Information
Revision date
2022-04-01
Product name
Retevmo
Product Synonyms
Loxo-292 Capsules
1.2.1 Relevant identified uses
Pharmaceutical
Manufacturer Name
Eli Lilly and Company
Emergency telephone
+1-317-276-2000, +1-800-424-9300
Icons in SDS
Company Information
company name
Eli Lilly and Company
e-mail address of the competent person responsible for the Safety Data Sheet
lilly_sds@lilly.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360, H371, H373
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified.
Health hazards
Germ cell mutagenicity Category 2 Reproductive toxicity Category 1B Specific target organ toxicity, single exposure Category 2 Specific target organ toxicity, repeated Category 2 exposure
Signal word
Danger
Hazard statements
H341 Suspected of causing genetic defects. H360 May damage fertility or the unborn child. H371 May cause damage to organs (bone marrow). H373 May cause damage to organs (gastrointestinal tract) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P264 Wash thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P281 Use personal protective equipment as required.
Response
P308 + P313 IF exposed or concerned: Get medical advice/attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise None known.
